Skip Navigation LinksHome > August 1987 - Volume 5 - Issue 4 > Effect of DOCA-Salt Treatment Duration and Anteroventral Thi...
Journal of Hypertension:
Article: PDF Only

Effect of DOCA-Salt Treatment Duration and Anteroventral Third Ventricle Lesions on a Plasma-Borne Sodium Pump Inhibitor in Rats*.

Songu-Mize, Emel; Bealer, Steven L.; Caldwell, Robert W.

Collapse Box

Abstract

We determined the effect of plasma obtained from rats treated with DOCA-salt for 6 and 28 days on sodium pump activity, measured as ouabain-sensitive Rb+ uptake in tail arteries from these rats. The effect of an electrolytic lesion in the area of the anteroventral third cerebral ventricle (AV3V) before DOCA-salt treatment was investigated in relation to the ability of plasma to inhibit vascular Na+ pump activity. Systolic blood pressures, plasma sodium and potassium concentrations, body weights and haematocrit were also measured. Six days after DOCA-salt treatment, there was a 22% suppression of vascular Na+ pump activity in these rats. This suppression was due to a plasma factor since plasma from these rats produced a similar degree of suppression in arteries isolated from untreated control rats. Furthermore, tail arteries from DOCA-salt rats treated for 6 days displayed normal Na+ pump activity when incubated in plasma from control rats or in Krebs-Henseleit buffer. There was no elevation of systolic blood pressure at the end of 6 days of treatment with DOCA-salt. Placement of an electrolytic brain lesion in the AV3V area before treatment with DOCA-salt abolished the ability of plasma to inhibit the vascular Na+ pump. Treatment with DOCA-salt for 28 days resulted in a significant increase in systolic blood pressure, a decrease in plasma potassium concentration, and a significant increase in vascular Na+ pump activity (26%). This elevation in pump activity appears to be due to a change in the artery rather than a stimulating factor in the plasma, since incubation of the arteries in both Krebs-Henseleit buffer and in plasma taken from control rats still resulted in increased Na+ pump activity. Our data indicate that, 6 days after DOCA-salt treatment there appears to be an inhibitor of the vascular Na+ pump in the plasma which is undetectable by bio-assay if the rats are lesioned in the AV3V region before this treatment. Twenty-eight days after DOCA-salt treatment, the vascular Na+ pump is stimulated; this is due not to a plasma factor, but to a change in the artery.

(C) Lippincott-Raven Publishers.

Login

Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.